MYRIAD GENETICS, INC. Deferred Tax Liabilities, Intangible Assets
MYRIAD GENETICS, INC. (MYGN) had Deferred Tax Liabilities, Intangible Assets of $17.00 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets · last filed 2026-02-24
- 2025-12-31: Deferred Tax Liabilities, Intangible Assets $17.00M.
- 2024-12-31: Deferred Tax Liabilities, Intangible Assets $55.50M.
- 2023-12-31: Deferred Tax Liabilities, Intangible Assets $84.20M.
- 2022-12-31: Deferred Tax Liabilities, Intangible Assets $93.80M.
| Period end | Deferred Tax Liabilities, Intangible Assets | Deferred Tax Liabilities, Intangible Assets as first filed |
|---|---|---|
| 2025-12-31 | $17.00M 10-K · filed 2026-02-24 | |
| 2024-12-31 | $55.50M 10-K · filed 2026-02-24 | |
| 2023-12-31 | $84.20M 10-K · filed 2025-02-28 | |
| 2022-12-31 | $93.80M 10-K · filed 2024-02-28 | |
| 2021-12-31 | $104.90M 10-K · filed 2023-03-01 | |
| 2020-12-31 | $144.00M 10-K · filed 2022-02-25 | |
| 2020-06-30 | $150.30M 10-KT · filed 2021-03-16 | |
| 2019-06-30 | $175.40M 10-KT · filed 2021-03-16 | |
| 2018-06-30 | $109.50M 10-K · filed 2019-08-13 | |
| 2017-06-30 | $177.70M 10-K · filed 2018-08-24 | |
| 2016-06-30 | $81.10M 10-K · filed 2017-08-09 | |
| 2015-06-30 | $69.40M 10-K · filed 2016-08-10 | |
| 2014-06-30 | $71.80M 10-K · filed 2015-08-12 | $71.75M 10-K · filed 2014-08-13 |
| 2013-06-30 | $438.00K 10-K · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |